J. Pihlajamaki et al., A major gene effect on fasting insulin and insulin sensitivity in familialcombined hyperlipidemia, DIABETES, 50(10), 2001, pp. 2396-2401
The most common inherited dyslipidemia, familial combined hyperlipidemia (F
CHL), is associated with insulin resistance. Whether insulin sensitivity in
these families is inherited is not known. Therefore, we investigated the i
nheritance of insulin sensitivity in 352 nondiabetic family members from 37
families with FCHL, 105 of whom had undergone testing using the hyperinsul
inemic-euglycemic clamp technique for the measurement of insulin sensitivit
y. First, complex segregation analysis of fasting insulin levels (both unad
justed and age-, age(2)-, and BMI-adjusted) was used for modeling of the va
riance in fasting insulin levels. In these analyses, Mendelian codominant i
nheritance (P = 0.320 for unadjusted and P = 0.295 for adjusted insulin val
ues) was not rejected over the most general model and fit the data signific
antly better than the sporadic model (P < 0.001). Polygenic and environment
al models were rejected (P < 0.001). The Mendelian codominant model explain
ed 44 and 45% of the variance in unadjusted and adjusted fasting insulin le
vels, respectively. The proposed genotypes of this locus, based on segregat
ion analysis, were associated with directly measured insulin sensitivity in
105 FCHL family members who underwent the hyperinsulinemic-euglycemic clam
p (P < 0.001). These results provide evidence for a major gene regulating i
nsulin sensitivity in FCHL families. Possible pleiotropic effects of this i
nsulin sensitivity locus on dyslipidemias in FCHL remain to be elucidated.